Normal view MARC view ISBD view

Treatment Options for Early-Stage Hepatocellular Carcinoma. [Review]

MedStar author(s):

Citation: Seminars in Interventional Radiology. 37(5):448-455, 2020 Dec.PMID: 33328700Institution: MedStar Medical Group | MedStar Washington Hospital CenterDepartment: RadiologyForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2020 ISSN:

0739-9529

Name of journal: Seminars in interventional radiologyAbstract: Patients with early stage hepatocellular carcinoma have good prognosis and are treated with curative intent. Although this cohort of patients is generally defined by limited tumor burden, good liver function, and preserved functional status, there remains utility in further stratification to optimize overall survival and limit post-operative morbidity and mortality. Transplant, resection, ablation, transarterial radioembolization, and transarterial chemoembolization, either as monotherapy or in combination, may play a crucial role in treating this cohort of patients depending on a multitude of factors. In this section, we review each treatment modality and provide general guidelines for patient selection. Copyright Thieme. All rights reserved.All authors: Sivananthan G, Tabori NEFiscal year: FY2021 Digital Object Identifier:

https://dx.doi.org/10.1055/s-0040-1720950

Date added to catalog: 2020-12-31

Holdings ( 1 )
Title notes ( 2 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	33328700	Available		33328700

Patients with early stage hepatocellular carcinoma have good prognosis and are treated with curative intent. Although this cohort of patients is generally defined by limited tumor burden, good liver function, and preserved functional status, there remains utility in further stratification to optimize overall survival and limit post-operative morbidity and mortality. Transplant, resection, ablation, transarterial radioembolization, and transarterial chemoembolization, either as monotherapy or in combination, may play a crucial role in treating this cohort of patients depending on a multitude of factors. In this section, we review each treatment modality and provide general guidelines for patient selection. Copyright Thieme. All rights reserved.

English